Form4insider filings, from the source

SEC Form 4 · accession 0001209191-17-018918

MAGELLAN HEALTH INC · MGLN

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Mostafa Kamal
Officer — CEO, Magellan Rx Management
Period of report
Mar 3, 2017
Accepted (ET)
Mar 7, 2017 · 5:38 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000019411

Table I — non-derivative securities

No Table I lines on this filing.

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Stock Options (right to buy)F2,F1$68.50Mar 3, 2017A19,923A—Mar 3, 2027Common Stock19,92319,923D
Performance-Based Restricted Stock UnitsF2,F3,F4$0.00Mar 3, 2017A6,821AMar 3, 2020—Common Stock6,8216,821D

Explanation of responses